Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Gastric HER2/Claudin18.2

Markus Moehler

MD

🏢University Medical Center Mainz🌐Germany

Professor, Department of Internal Medicine

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Markus Moehler is a key investigator in gastric cancer immunotherapy and targeted therapy trials in Europe. He has been centrally involved in the clinical development of zolbetuximab for Claudin 18.2-positive gastric cancer. His translational research bridges molecular characterization with novel therapeutic interventions.

Share:

🧪Research Fields 研究领域

Gastric cancer
Immunotherapy
Claudin 18.2
Checkpoint inhibitors
Translational GI oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Markus Moehler 的研究动态

Follow Markus Moehler's research updates

留下邮箱,当我们发布与 Markus Moehler(University Medical Center Mainz)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment